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Abstract: This work analyses the chitin-binding and catalytic domains of the human macrophage
chitotriosidase and investigates the physiological role of this glycoside hydrolase in a complex
mechanism such as the innate immune system, especially its antifungal activity. Accordingly,
we first analyzed the ability of its chitin-binding domain to interact with chitin embedded in fungal
cell walls using the b-lactamase activity reporter system described in our previous work. The
data showed that the chitin-binding activity was related to the cell wall composition of the fungi
strains and that their peptide-N-glycosidase/zymolyase treatments increased binding to fungal by
increasing protein permeability. We also investigated the antifungal activity of the enzyme against
Candida albicans. The antifungal properties of the complete chitotriosidase were analyzed and
compared with those of the isolated chitin-binding and catalytic domains. The isolated
catalytic domain but not the chitin-binding domain was sufficient to provide antifungal activity.
Furthermore, to explain the lack of obvious pathologic phenotypes in humans homozygous for a
widespread mutation that renders chitotriosidase inactive, we postulated that the absence of
an active chitotriosidase might be compensated by the expression of another human hydrolytic
enzyme such as lysozyme. The comparison of the antifungal properties of chitotriosidase
and lysozyme indicated that surprisingly, both enzymes have similar in vitro antifungal
properties. Furthermore, despite its more efficient hydrolytic activity on chitin, the
observed antifungal activity of chitotriosidase was lower than that of lysozyme. Finally,
this antifungal duality between chitotriosidase and lysozyme is discussed in the context of
innate immunity.
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Introduction
In higher vertebrates, the innate immune system is
the first line of defense against pathogens. It com-
prises cells and mechanisms that defend the host
from infections by other organisms, in a nonspecific
manner. It does not confer long-lasting or protective
immunity to the host but plays an important role in
triggering and optimizing the adaptative immune
response. The first step in the activation of the
innate immune system is the recognition of patho-
gen-associated molecular patterns (PAMPs) by C-
type lectin receptors and Toll-like receptors (TLRs).1
TLRs are expressed predominantly in antigen-proc-
essing and -presentation cells such as macrophages,
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neutrophils, and dendritic cells, but their expression
is not restricted to these cell types.
PAMPs are common molecules present on the
cell surface of microbes including lipopolysaccharide
(Gram-negative bacteria), peptidoglycan (PG), and
lipoteichoic acid (Gram-positive bacteria). In the
outer surface of the Candida albicans cell wall, N-
and O-linked mannosyl groups of glycoproteins,
phospholipomannan, and b-glucans have been
described as PAMPs.2,3 Once the TLRs are attached
to specific PAMPs, changes in the intracellular
domain result in the activation of signaling events
such as the translocation of transcription factors,
cytokine modulation, and interferon-stimulated
gene regulation leading to inflammatory responses
and/or the release of antimicrobial agents. These
antimicrobial agents could be at least classified into
three types: (i) defensins, (ii) whey acidic protein
motif containing proteins, and (iii) hydrolytic
enzymes.3
Cell walls are essential for the survival of fungal
cells. Digestion and inhibition of cell wall synthesis
lead to cell lysis due to the high internal turgor
pressure. Thus, substances that interfere with cell
wall synthesis are considered as potential antifungal
agents. In the most characterized yeast, Saccharo-
myces cerevisiae, the cell wall contains b(1 ! 3)-glu-
cans, b(1 ! 6)-glucans, chitin, and mannoproteins
that are linked together. Mannoproteins are
attached to b(1 ! 6)-glucans through a remnant of
glysosylphosphatidylinositol anchors containing five
a-linked mannosyl residues.4 The b(1 ! 6)-glucans
have some b(1 ! 3)-linked branches, and it is to
these branches that the reducing termini of chitin
chains appear to be attached in a b(1 ! 4) or b(1 ! 2)
linkage. The reducing ends of b(1 ! 6)-glucans
are connected to the nonreducing terminal glucoses of
b(1 ! 3)-glucans through a yet uncharacterized link-
age. Because of their rigidity that result from the
numerous crosslinks, the polysaccharides of fungal cell
wall seem to have a major structural function and
determine the shape of fungal cells, whereas the man-
noproteins may act as ‘‘fillers’’ and are important
determinants of the cell wall permeability.4
Chitinases catalyze the hydrolysis of chitin,
which is a linear b(1 ! 4)-linked polymer of N-ace-
tylglucosamine units. Although chitin is not a com-
ponent of human tissues, it is a major component of
many pathogenic organisms’ cell walls including not
only fungi but also insects and nematodes. Chitotrio-
sidase and acidic mammalian chitinase are two
human chitinases that have been recently discov-
ered. The former is expressed by macrophages and
has received a lot of attention. In particular, it is a
valuable diagnostic tool for monitoring the efficiency
of the Gaucher’s disease therapy.5–7 The latter is
relatively abundant in the gastrointestinal tract and
is characterized by an acidic isoelectric point and a
distinct second pH optimum around 2.8 Both chiti-
nases are synthesized as 50-kDa proteins each con-
taining a 39-kDa N-terminal catalytic domain, a hinge
region, and a C-terminal chitin-binding domain.
The production, storage, and secretion of chito-
triosidase by macrophages and neutrophils, prime
components of the innate immune system, suggest a
role in innate immunity.9 Such a role has been
described for many plant chitinases.10,11 Further-
more, van Eijk et al. showed that human chitotriosi-
dase inhibited the growth of Cryptococcus neoformans
and Mucor rouxii, and totally inhibited switching of a
C. albicans isolate from yeast/single cell to hyphal
growth.9,12 It was also demonstrated that the injec-
tion of recombinant human chitotriosidase improved
survival in neutropenic mouse models of Candidiasis
and Aspergillosis.12
Individuals homozygous for a 24-bp duplication
within Exon 10 of the chitotriosidase gene have no
functional chitotriosidase. According to Masoud
et al.,13 the prevalence of homozygosity for this enzy-
matic activity deficiency among patients who had
survived Candida sepsis suggests that chitotriosi-
dase deficient persons are more susceptible to
develop fungal infections. However, Hall et al.14
suggested that the immune system has several tiers
of redundancy making sure that organisms remain
viable despite defects in innate immunity genes.
In this study, we decided to compare the anti-
fungal properties of the complete human macro-
phage chitotriosidase and its related domains, the
chitin-binding and the catalytic domains, against C.
albicans, which is one of the main causes of mortal-
ity in immunocompromised individuals. Contrary to
what was observed for plant chitinases,15–17 we dem-
onstrated that the catalytic domain is sufficient to
present an antifungal activity and has the tendency
to be even more efficient than the entire enzyme. In
contrast, the isolated chitin-binding domain does not
present any antifungal properties as it is the case
for a few chitin-binding proteins.18–20 We have also
asked whether the mutation that renders the human
macrophage chitotriosidase inactive may be compen-
sated by enzymes such as human lysozyme that has
not only a documented action against bacteria but
also a less-known antifungal activity.21,22
Results
Antifungal activity of the human macrophage
chitotriosidase
The chitin-binding domain
Functionalization of the chitin-binding domains. To
investigate the antifungal activity of the chitin-bind-
ing domain, we first analyzed its chitin-binding
activity for chitin embedded in fungal cell walls. For
that purpose, we used the b-lactamase reporter
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system described in our previous works.23,24 These
works demonstrated the efficiency of the class A b-
lactamase BlaP for the analysis of the properties of
carbohydrate-binding domains. Using genetic engi-
neering, we inserted the chitin-binding domains of
the human macrophage chitotriosidase, the Acidic
Mammalian Chitinase, and the one of the chitinase
A1 from Bacillus circulans called ChBDI, ChBDII
and ChBDIII, respectively, into a solvent-exposed
loop of the carrier protein BlaP.23–26 Indeed, it was
interesting to compare the chitin-binding properties
of ChBDI with another human chitin-binding do-
main (ChBDII) and also a prokaryotic chitin-binding
domain (CBDIII). The resulting genetic construc-
tions encoding the chimeric proteins called
BlaPChBDI, BlaPChBDII, and BlaPChBDIII were
used to transform E. coli JM109 to achieve the over-
expression of three soluble chimeric proteins in the
periplasmic space. The proteins added with a poly-
histidine tag were extracted from the periplasm by
an osmotic cold shock and purified by chelation
affinity and anion exchanger chromatographies.
To check that the insertion of the three chitin-
binding domains does not alter the b-lactamase
activity of the protein carrier, kinetic parameters of
nitrocefin hydrolysis were determined and compared
with those of the parental b-lactamase (BlaP SmaI),
harboring the engineered insertion loop. Data pre-
sented in Table I show that whatever the nature of
the chitin-binding domain inserted into BlaP is the
b-lactamase moiety remains active and exhibits
kinetic parameters similar to those of the parental
enzyme.
Next, to verify the biological functionality of the
inserted chitin-binding domains, chitin-binding
assays on insoluble purified b-chitin from crab shells
were performed by monitoring the immobilized b-lac-
tamase activity (Fig. 1). In these binding assays, we
took into account the respective kinetic parameters
of the different hybrid proteins to compare their
binding activities. Although the immobilization of
the enzyme onto a surface can affect its catalytic
properties, we reasonably assume that this would
affect the activity of the different chimeric proteins
in the same way and thereby normalized the data
using the kinetic parameters calculated for the
proteins in solution. The results show that the
chitin-binding activity of all the inserted domains is
preserved and that the affinities for chitin increase
in the following order ChBDII < ChBDI < ChBDIII.
The carrier protein without any insert (BlaP SmaI)
was used as a negative control. In these experi-
ments, we took into account the respective kinetic
parameters of the different hybrid proteins. The rel-
ative equilibrium association constant (Kr) of the
three chimeric proteins for purified insoluble chitin
was also determined by the method described by
Gilkes et al.28 The calculated Kr values (Table II)
were in the same value range compared with those
observed for other classical carbohydrate-binding
domains29 confirming that the chitin-binding
domains were still functional after insertion into the
b-lactamase BlaP. The Kr values increase in the fol-
lowing order ChBDI < ChBDII < ChBDIII. The pro-
karyotic chitin-binding domain thus has the highest
affinity for purified insoluble chitin. The difference
Table I. Kinetic Studies of the Different Hybrid b-Lactamases
BlaP (SmaI) BlaPChBDI BlaPChBDII BlaPChBDIII
KM (lM) 40 6 2 20 6 1 41 6 1 56 6 2
kcat (s
1) 490 6 20 195 6 5 340 6 10 415 6 7
kcat/KM (lM
1 s1) 12.2 6 0.8 9.7 6 0.5 8.3 6 0.3 7.4 6 0.3
The substrate was 100 lM nitrocefin. The values are compared with those reported for the parental enzyme without any
insert (BlaP SmaI).27 Each kinetic has been performed twice in triplicates. These values represent the averages 6 SD of
the two independent experiments.
Figure 1. Interaction of the different hybrid proteins with
purified insoluble chitin. Binding assay mixtures contained
10 mg (dry weight) of insoluble chitin and 25 pmol of
protein in 500 lL of 50 mM sodium phosphate buffer, 150
mM NaCl (pH 7.4). Assay mixtures were incubated for 2 h
at room temperature for binding. After removing the
supernatant, the pellet was washed three times and
incubated for 2 min with 1 mL of nitrocefin (100 lM). After
filtration of the suspension, the absorbance of the filtrate
was measured at 482 nm. This experiment has been
repeated three times (each in duplicates). The bars
represent the averages 6 SD of these independent
experiments. Error propagation was used to normalize the
interaction of the different chimeric proteins with their
respective kcat.
Vandevenne et al. PROTEIN SCIENCE VOL 20:1451—1463 1453
between ChBDII and ChBDI affinities observed
when using the two different methods might be
explained by the fact that the Kr values were deter-
mined in thermodynamic equilibrium conditions. In
contrast, the immobilized enzymatic activities deter-
mined in the first experiment were measured after
washings that disrupted this equilibrium.
Interaction of the chitin-binding domains with
fungal cell walls. To study the chitin-binding ac-
tivity in the context of fungal cell walls, we com-
pared the fungal binding properties of the three chi-
meric proteins with different pathogenic fungal
species such as C. albicans, Candida tropicalis, C.
neoformans, M. rouxii, and Trichoderma reesei. The
immobilized b-lactamase activities of the cell wall
obtained by incubating the hybrid proteins with the
different fungal species are presented in Figure 2.
As described earlier, the carrier protein without
insert (BlaP SmaI) was used as a negative control
and we took into account the respective kinetic pa-
rameters of the different hybrid proteins to compare
their binding activities. In addition, the filamentous
Gram-positive bacterium Streptomyces lividans TK24
was used as a negative control, because it does not
contain any chitin. The data indicated that all the chi-
meric proteins recognized fungal cell wall chitin and
that despite the fact that the prokaryotic chitin-bind-
ing domain had the higher affinity for purified chitin,
the chitin-binding domain of the human macrophage
chitotriosidase exhibits the strongest affinity for fun-
gal cell walls in every tested fungal species. The
observed binding properties also depend on the fungal
species suggesting that the chitin content and/or
accessibility differs in the different tested fungi.
It should be noted that in all these binding
assays, the read-out was indirect and could not be
confirmed by performing some competition type
experiments using soluble chitin oligomers to com-
pete off the different reporter proteins as we previ-
ously described that these chitin-binding domains
only recognize insoluble chitin.23
Importance of fungal cell wall permeability on
chitin accessibility. Fungal cell wall is composed
of a chitin layer buried under a bulky b-1,3-glucan
and a mannoprotein layer, which considerably limit
chitin accessibility. To investigate the importance of
chitin accessibility on chitin recognition by ChBDI
and thus on the in vivo chitinolytic activity of the
human macrophage chitotriosidase, we pretreated
the different fungal strains with Type XIV protease,
peptide-N-glycosidase F (PNGase F), or zymolyase
before proceeding to binding assays with BlaPChBDI.
Type XIV protease is a mixture of at least three pro-
teolytic activities that target the peptide moieties of
the mannoprotein layer. PNGase F is usually used to
deglycosylate proteins, it cleaves the entire glycan
moiety of mannoproteins. Zymolyase is a mixture of a
b-1,3-glucan hydrolase and an alkaline protease,
which may change the structure of the fungal cell
wall to facilitate penetration of the glucan b-1,3-hy-
drolase. The data presented in Figure 3 indicate that
for all the tested fungi, the different enzymatic treat-
ments increase the binding of BlaPChBDI to chitin in
the following order zymolyase > PNGase > Type XIV
protease. This indicates that chitin accessibility is im-
portant in the recognition of fungi by chitin-binding
proteins. Our data also indicate that removal of man-
nan from the cell wall is sufficient to improve the per-
meability to the hybrid protein. The slight ameliora-
tion of the binding observed when fungi are treated
with the Type XIV protease suggests that glycosyla-
tion of proteins protect them against proteolysis.
Table II. Determination of the Relative Equilibrium
Association Constant (Kr) for the Three Chimeric
Proteins with Purified Insoluble Chitin, as Described
By Gilkes et al.28
BlaPChBDI BlaPChBDII BlaPChBDIII
Kr (L g
1) 5.4 6 0.5 7.4 6 0.7 10.1 6 0.3
Each binding constant has been determined in two inde-
pendent experiments (each performed in triplicates) using
very low protein concentrations (see Materials and Meth-
ods section). The presented values correspond to the aver-
ages 6 SD of these two independent experiments.
Figure 2. Interaction of the different chimeric proteins with
fungal cell wall chitin. The cells were recovered by
centrifugation of the culture and washed twice with 50 mM
sodium phosphate buffer pH 7.5. The cell suspensions
were incubated for 2 h with 25 pmol of each protein in 500
lL of 50 mM sodium phosphate buffer pH 7.5, 150 mM
NaCl. After removing the supernatant, the cell pellets were
washed three times and incubated for 35 min with 1 mL of
nitrocefin (100 lM). After filtration of the suspension, the
absorbance of the filtrate was measured at 482 nm. This
experiment has been repeated three times (each in
duplicates). The bars represent the averages 6 SD of these
independent experiments. Error propagation was used to
normalize the interaction of the different chimeric proteins
with their respective kcat.
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The catalytic domain
Functionality of the catalytic domain. Besides
the production of the isolated chitin-binding domain,
we decided to express the catalytic domain to assess
the contribution of both domains in the antifungal ac-
tivity of the human macrophage chitotriosidase. The
isolated catalytic domain, called Cat_chito, was suc-
cessfully produced in a soluble form. The comparison
of the far UV circular dichroism and fluorescence
spectra of Cat_chito with those of the entire chitotrio-
sidase [Fig. 4(a,b)] suggests that the isolated catalytic
domain is correctly folded. Next, we investigated the
ability of Cat_chito to hydrolyze different chitin forms
such as soluble chitooligomers (4-MU-chitotriose),
insoluble chitin [carboxymethyl (CM)-chitin-Remazol
Brilliant Violet (RBV)], and crystalline chitin (chitin
powder extracted from crab shells). Results are
presented in Figure 5(a–c). The data show that the
isolated catalytic domain hydrolyzes soluble chitoo-
ligomers with a catalytic efficiency (11,100 6 200 lM/
min1) higher than that of the entire chitinase
(93006 200 lM/min1) with a 380 nM protein concen-
tration [Fig. 5(a)]. In contrast, if insoluble chitin
hydrolysis is quite similar for both proteins [Fig.
5(b)], hydrolysis of crystalline chitin is severely
affected when the chitin-binding domain is deleted
[Fig. 5(c)]. Altogether these data suggest that the
chitotriosidase catalytic domain folds correctly into
an enzymatically active chitinase.
It should be noted that in this assay, we used
crab shell chitin as an insoluble chitin substrate
that seems to be the most suitable and commonly
used insoluble chitin, although it is unlikely to be a
lysosomal component and therefore a common sub-
strate for the chitotriosidase.
Antifungal activities of the chitin-binding and
catalytic domains. The respective roles of the
chitin-binding and catalytic domains in the chitotrio-
sidase antifungal activity have not been investigated
yet. To assess their contribution, we compared the
effects of the entire chitotriosidase, Cat_chito and
BlaPChBDI on C. albicans viability. In this aim, C.
albicans viability assays were realized (Table III). In
these assays, C. albicans yeast cells were exposed to
the different tested proteins during 2 h. After
adequate dilution, cells were plated on solid media
to estimate the survival. The data indicate that at
equal concentration, the susceptibility to the protein
Figure 3. Interaction of BlaPChBDI with fungal chitin cell
wall after treatment with zymolyase, PNGase, and Type XIV
protease. In this experiment, the washed cells were
incubated in the presence of the different hydrolytic
enzymes before incubation with the chimeric proteins. After
this treatment, cells were successively washed twice with
50 mM sodium phosphate buffer, incubated with the
different hybrid proteins, washed again, and incubated with
nitrocefin as described above. Finally, absorbance of the
filtrate was measured at 482 nm. This experiment has been
repeated three times (each in duplicates). The bars
represent the averages 6 SD of these independent
experiments.
Figure 4. Far-UV CD (A) and intrinsic fluorescence spectra (B) of the entire chitotriosidase (*) and its catalytic domain
(Cat_chito) (l). Spectra were recorded in 50 mM sodium phosphate–citrate buffer (pH 5.6).
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treatment was very similar for the complete chitinase
compared with its catalytic domain, with a slightly
stronger effect observed for the catalytic domain. This
result is in contradiction with previous works15–17
describing that the catalytic domains of many plant
chitinases did not present any antifungal activity and
that the presence of the chitin-binding domain was
essential for the antifungal properties. Our data also
show that the chitin-binding domain does not present
any antifungal activity contrary to what has been
demonstrated for a few chitin-binding proteins18–20
that interfere with cell wall synthesis by binding to
nascent chitin, by crosslinking the polymer or by
interfering with growth polarity.
Human macrophage chitotriosidase versus
human lysozyme
In addition to its well-documented antibacterial
effects,30 it was demonstrated that in some in vitro
conditions, exposure of C. albicans to the hen egg
lysozyme causes a loss of viability.21,31,32 Thus, we
have compared the antifungal activities of the
human macrophage chitotriosidase to one of the
human lysozyme against C. albicans with the idea
that human lysozyme might compensate chitotriosi-
dase deficiency in homozygous individuals for a
mutation that inactivates the human chitinase. To
do so, we realized three different experiments to
investigate the effects of these two enzymes on (i)
the inhibition of the switch between the yeast and
hyphal forms of C. albicans, (ii) the fungus viability,
and (iii) its biofilm formation inhibition.
Inhibition of C. albicans switch between the
yeast and filamentous forms. Microscopy data
analysis (Fig. 6) shows that both human enzymes
are able to inhibit C. albicans switch from the yeast
to the hyphal forms. Furthermore, the minimal
inhibitory concentration of lysozyme required to
observe this effect is twice lower than the one
required when using the chitotriosidase. The same
result was obtained when the experiments were
performed on solid media according to the procedure
as described by van Eijk et al. (data not shown).
Effect on C. albicans viability. C. albicans via-
bility assays have been achieved as described earlier.
The data presented in Table IV indicate that, at
equal concentration, the reduction of survival was
twice more important for lysozyme than the one
Figure 5. Comparison of the chitinolytic activities of the
entire chitotriosidase and its catalytic domain (Cat_chito) on
(A) soluble chitooligomer (4-MU-chitotriose), (B) insoluble
chitin (CM-Chitin-RBV), and (C) crystalline chitin powder
from crab shells.
Table III. BlaPChBDI (FBC), Cat_chito (FCat), and








0 0.52 6 0.12 0.45 6 0.11
The fungicidal activity F was calculated using the following
formula F ¼ (CFU of the control cell suspension – CFU of
the tested cell suspension)/(CFU of the control cell suspen-
sion). This value is comprised between 0 and 1, the higher
the F value, the higher the sensitivity of the yeast to the
protein. Each protein was used at a concentration of 68
lM. Four independent experiments have been realized
(each in triplicates). These values represent the averages 6
SD of these independent experiments.
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observed for chitotriosidase. Interestingly, no signifi-
cant dose-dependent effect was observed for the two
tested enzymes which might be explained by the fact
that the cell wall permeability causes a bulking that
would limit protein diffusion.
Inhibition of C. albicans biofilm formation.
Filamentation is a physiological state required for
initiating the C. albicans biofilm formation. We
examined the effect of chitotriosidase and lysozyme
on biofilm formation using the method described by
Ramage et al.33 Biofilm formation was monitored
after 48 h of adherence in the presence of the two
isolated enzymes or in combination. The results
presented in Figure 7 indicate that as expected, the
antifungal agent fluconazole (positive control) dra-
matically affects C. albicans biofilm formation.34
Treatments with chitotriosidase and lysozyme
resulted in a lesser but significant decrease in the
biofilm formation. The data also indicate that at
equal protein concentration, lysozyme exhibits the
stronger effect.
In all these assays, no significant increase in the
antifungal activity was observed when both enzymes
were combined (data not shown) suggesting that no in
vitro synergy occurs between these two enzymes. This
absence of synergy could be explained by the fact that
the two enzymes target the same substrate.
Antibacterial effect. It is well established that
lysozyme catalyzes the hydrolysis of b-1,4-linkages
between N-acetylmuramic acid and N-acetyl-D-gluco-
samine in PG. However, we show here that this
enzyme also has an antifungal effect. Thus, we inves-
tigated the possible hydrolysis of the b-1,4-linkages
between N-acetyl-D-glucosamine units in chitin by
lysozyme, and inversely, it was interesting to check
Figure 6. Analysis of the chitotriosidase and lysozyme antifungal activity on C. albicans switching from yeast to hyphal forms.
Hyphae formation of C. albicans was induced by shifting the growth temperature from 28 to 37C during 2 h. Lysozyme and
chitotriosidase were added at 20, 10, 5, and 2.5 lM to assess their antifungal activities. This experiment has been repeated
four times.
Table IV. Fungicidal Effects of Various Lysozyme (FL)







68 0.75 6 0.12 0.38 6 0.04
340 0.81 6 0.19 0.47 6 0.06
680 0.87 6 0.21 0.52 6 0.11
The fungicidal activity F was calculated as described in Ta-
ble III. Four independent experiments have been realized
(each in duplicates). These values represent the averages
6 SD of these experiments.
Figure 7. Analysis of C. albicans biofilm formation in the
presence of chitotriosidase and lysozyme. All the
absorbance values were standardized as a percentage;
100% corresponding to the absorbance value obtained for
the control (cells incubated with buffer). The results are the
means of two independent experiments each carried out
with 20 replicates for each tested enzyme.
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whether chitotriosidase could also hydrolyze PG in
addition to its chitin hydrolysis activity. The data
presented in Figure 8(a,b) indicate that although
lysozyme exhibits a stronger antifungal activity than
chitotriosidase, it weakly hydrolyzes insoluble chitin
(CM-chitin-RBV) and has no activity on soluble chi-
tooligosaccharides (4-MU-chitotriose). In addition we
investigated the hydrolytic activity of the chitotriosi-
dase against peptidoglycan. Figure 9(a,b) shows that
the enzyme is unable to hydrolyze purified PG but
has a slight effect on Bacillus subtilis cell lysis. In
contrast, as expected, lysozyme exhibits a strong
activity against both purified PG and bacteria.
Discussion
The results of the present investigation are consist-
ent with the following conclusions. The comparison
of the fungal chitin interaction properties of ChBDI,
ChBDII, and ChBDIII, which correspond to the chi-
tin-binding domains of the human macrophage chi-
totriosidase, the human acidic mammalian chiti-
nase,8 and chitinase chiA1 from B. circulans,29,35
respectively, has demonstrated that ChBDI exhibits
the strongest affinity supporting the role of the
human chitotriosidase in defense against chitin-con-
taining pathogens. We also showed that the recogni-
tion of the chitin embedded in fugal cell wall was de-
pendent of chitin accessibility as enzymatic
treatments of the tested fungi result in a significant
increase of ChBDI binding. This result emphasizes
the importance of chitin accessibility in the recogni-
tion and antifungal activity of the chitotriosidase.
The analysis of the functional contribution of
the chitin-binding (ChBDI) and catalytic (Cat_chito)
Figure 8. Comparison of chitotriosidase and lysozyme activities on (A) a soluble chitooligomers (4-MU-chitotriose) and (B)
insoluble chitin (CM-Chitin-RBV).
Figure 9. Comparison of the activities of chitotriosidase and lysozyme on (A) purified fluorescein-labeled PG and (B) Bacillus
subtilis cells. For the bacterial cell lysis experiment, the measured absorbance values were standardized as a percentage.
100% corresponding to the absorbance value obtained for the control (bacterial culture without added enzyme) at the same
incubation time. The black and the gray bars represent the values obtained for lysozyme and chitotriosidase, respectively.
This experiment has been repeated three times (each in duplicates). The bars represent the averages 6 SD.
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domains in both chitin hydrolysis and the antifungal
activity of the chitotriosidase demonstrated that
addition of ChBDI to a C. albicans cell suspension
did not resulted in a further decrease in survival.
Surprisingly, the complete chitinase and the cata-
lytic domain presented similar antifungal properties,
the latter exhibited a slightly stronger effect.
As the chitotriosidase chitin-binding domain de-
letion did not result in a decrease of either the anti-
fungal activity or the soluble and insoluble chitin
hydrolysis, these data raise the question of the role
of this domain in a human chitinase since this do-
main only seems to be important for crystalline chi-
tin hydrolysis [Fig. 5(c)].
In this study, we also investigated the ability of
lysozyme to complement a chitotriosidase deficiency.
The results indicate that, in our in vitro conditions,
no synergic effect occurred between these two
enzymes in fungal growth or fungal biofilm forma-
tion inhibition experiments. But surprisingly, our
data showed that, at the same concentration, lyso-
zyme exhibited a stronger antifungal activity than
chitotriosidase. We suggest that chitotriosidase and
lysozyme are not synergistic in their antifungal
activities because they share a common substrate
since insoluble chitin both in vitro (on crab shell chi-
tin) and in vivo (on fungal cell walls) is hydrolyzed
by both enzymes. We believe that the higher anti-
fungal activity observed for lysozyme is due to its
smaller size compared to the one of the chitotriosi-
dase. Indeed, the molecular masses of chitotriosidase
and lysozyme are 50 and 14.7 kDa, respectively. As
chitin accessibility is strongly decreased by the pres-
ence of a b-(1-3)-D-glucan layer and a mannoprotein
layer that act as fillers,4 we postulated that lyso-
zyme could access the fungal cell chitin much more
easily than chitotriosidase. Indeed, an estimate of
fungal wall pore size predicts that diffusion through
the fungal wall could be difficult for proteins larger
than 15 to 20 kDa.18 A slight increase in the anti-
fungal activity of the catalytic domain (40 kDa) com-
pared to what was observed for the complete chiti-
nase supports this hypothesis.
The observed stronger antifungal activity of ly-
sozyme suggests that in individuals lacking an
active chitotriosidase, lysozyme could be expressed
as an alternative as it was suggested by Hall et al.9
But we cannot exclude the expression of other
enzymes such as proteases or other glycoside hydro-
lases that would facilitate the diffusion of chitotriosi-
dase or lysozyme through the cell wall of pathogenic
fungi by degrading the other components of the
fungal cell wall.
In conclusion, we have particularly discussed
the direct role of the chitotriosidase in immunity by
inhibiting fungal growth. But we do not exclude that
this enzyme could indirectly be involved in immu-
nity by releasing some degradation compounds from
the fungal cell walls that would activate the immune
system by interacting with TLRs as postulated by
Netea et al.2
In this study, we also demonstrated for the first
time that human lysozyme that is usually associated
with defense against bacteria also presents an anti-
fungal activity that is even higher than that of chito-
triosidase, the human chitinase reported to be an
antifungal protein.
Materials and Methods
Construction, expression, and purification of
the hybrid proteins
The three hybrid proteins were constructed,
expressed, and purified as described previously.23,24
Kinetic studies of the hybrid b-lactamases
The kinetic parameters of the purified bifunctional
hybrid b-lactamases were determined using a
150 lM nitrocefin substrate solution prepared in
50 mM sodium phosphate buffer at pH 7. The initial
rates of hydrolysis were monitored at 482 nm. The
Km and kcat values were calculated by fitting the
data to the Henri-Michaelis equation and its linear-
ized form according to Hanes.36
Binding assay of the hybrid b-lactamases to
purified insoluble chitin
Identical amounts (50 nM) of each chimeric protein
and of the parental b-lactamase were incubated for
2 h with the same amount (10 mg) of insoluble chitin
(Sigma). The mixtures were centrifuged at 13,000g
during 10 min to separate the supernatants contain-
ing the unbound proteins from the pellet containing
chitin with the captured protein. The pellets were
washed three times with 50 mM sodium phosphate
buffer, 500 mM NaCl and then incubated in the pres-
ence of 150 lM nitrocefin for 1 min at 25C. The sus-
pension was rapidly filtered, and the absorbance of
the hydrolysis product was measured at 482 nm.
Determination of Kr
Binding assays were conducted as follows: various
concentrations of the chimeric protein (25 nM–3 lM)
were incubated in the presence of 10 mg of chitin in
a final volume of 500 lL of 50 mM sodium phos-
phate buffer, 150 mM NaCl, pH 7.5 at 22C with
continual mixing. The mixtures were centrifuged at
13,000g for 15 min at 4C and the supernatant
containing the free proteins was collected. The free
protein concentration was determined with the help
of the reporter b-lactamase activity. The amount of
bound protein was calculated as the difference
between the initial protein concentration and the free
protein concentration after binding. The relative equi-
librium association constants (Kr) were determined
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where [B] is the concentration of bound ligand (mol
g chitin–1), [F] the concentration of free ligand
(molar), [N0] the concentration of binding sites in
the absence of ligand, a the number of lattice units
occupied by a single ligand molecule, and Ka the
equilibrium association constant (L mol1). The Ka
value cannot be isolated from this equation but the
relative equilibrium association constant, Kr (L g
chitin1) is defined as:
Kr ¼ ½N0Ka
Expression of the human chitotriosidase
and its catalytic domain in Pichia pastoris
Recombinant human chitotriosidase and its catalytic
domain were produced using the pPIC9K P. pastoris
expression vector (Invitrogen) as described by Grate-
panche et al.37 Briefly, the genes encoding the cata-
lytic domain of the chitotriosidase and the complete
enzyme (GenBank, gi:4502808) followed by a His6-
tag on the C-terminal ends were amplified from the
plasmid pReceiver-YAD (GeneCopoeiaTM) and cloned
into the pPIC9K vector (Invitrogen) by standard
methods. The pPIC9K plasmid contains the a-factor
secretion signal that directs the recombinant protein
into the secretory pathway. The constructs were
digested with Sal I and used to transform P. pastoris
strain SMD168 by electroporation. This resulted in
insertion of the constructs at the AOX1 locus of P.
pastoris, generating a Hisþ Mutþ phenotype. Trans-
formants were selected for the Hisþ phenotype on
2% agar containing regeneration dextrose biotin (1M
sorbitol, 2% dextrose, 1.34% yeast nitrogen base, 4 
105% biotin, and 0.005% of L-glutamic acid, L-me-
thionine, L-lysine, L-leucine, and L-isoleucine) me-
dium and then further selected for high copy num-
ber by their ability to grow on 2% agar containing
1% yeast extract, 2% peptone, 2% dextrose medium,
and the G418 antibiotic at various concentrations
(0.5–4 mg/mL; Invitrogen). The proteins were
expressed in a shaker flask and harvested 72 h after
induction by methanol.
Purification of the recombinant chitotriosidase
and its catalytic domain
The proteins were purified by using a cation
exchange column (P-Sepharose, Pharmacia) equili-
brated in the first purification step with a 50 mM
acetate buffer pH 5 (Buffer A). The P. pastoris super-
natants dialyzed against the same buffer were
applied onto the column. Elution was performed by
a linear NaCl (0–1M) gradient. The active fractions
eluted at 600 mM NaCl were pooled and dialyzed
against Buffer B (50 mM sodium phosphate buffer,
150 mM NaCl, pH 7.5) for the second purification
step on an Ni-NTA-Sepharose column (Novagen,
USA) equilibrated with Buffer B. The column was
washed with seven column volumes of the same
buffer, three column volumes of Buffer B þ 2M
NaCl, and three column volumes of Buffer B þ
10 mM imidazole. Elution was performed with an
increasing linear (10–500 mM) imidazole gradient in
Buffer A. Active fractions eluted at 200 mM imidaz-
ole and yielded a single band on sodium dodecyl
sulfate polyacrylamide gel electrophoresis analysis.
Proteins integrity was verified by both N-terminal
sequencing using the Edman degradation procedure
and electrospray ionization mass spectrometry. For
both proteins, we observed a difference (400 Da)
between the theoretical and experimental molecular
weights, this difference was explained by the analy-
sis of the N-terminal sequence of the two proteins.
Results indicated that both sequences contained four
residues of the a-factor signal peptide (Glu–Ala–
Glu–Ala) incorrectly cleaved by P.pastoris endopro-
teases kex2. Furthermore, a weak heterogeneity is
also observed for both proteins with the presence of
species that differ from each other by increments of
162 kDa, this has been attributed to a fortuitous gly-
cosylation of the proteins.
Detection of fungal chitin
A colony of the tested fungi (C. albicans [the American
Type Culture Collection (ATCC) 10231-IHEM3731],
C. tropicalis (IHEM6246), C. neoformans (ATCC
32265-IHEM3969), T. reesei (ATCC 26921-IHEM4122)
provided by the Belgian Co-ordinated Collections of
Microorganisms andM. rouxii (ATCC 44260) provided
by ATCC) was inoculated into 30 mL of YPD medium
containing 2% dextrose and grown at 28C for 20 h. To
detect chitin, 4.8 mL of this culture (DO600 nm ¼ 0.5)
was pelleted by centrifugation and washed twice with
50 mM sodium phosphate buffer pH 7.5. The pellet
was then resuspended in 500 lL of phosphate buffer
containing 5 pmol of each chimeric protein. Incubation
was performed at 4C during 2 h under continuous
mixing. The cell suspensions were centrifuged at
8000g during 10 min to separate the supernatant con-
taining the unbound protein from the pellet containing
chitin with the captured protein. The pellets were
washed three times with 50 mM sodium phosphate
buffer, 0.2% Tween and then incubated in the presence
of 1 mL of 100 lM nitrocefin for 35 min at 25C. The
suspension was rapidly filtered and the absorbance of
the filtrate was measured at 482 nm. Two negative
controls were made, the first one using the parental
b-lactamase BlaP without inserted chitin-binding
domain and the second using the filamentous
bacterium S. lividans TK24.
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Detection of fungal chitin in the presence of
zymolyase, PNGase, and protease
Three different enzymes were used in these assays:
zymolyase (or lyticase 20T; ICN Immuno Biologicals,
Costa Mesa, CA); PNGase F (from Elizabethkingia
meningoseptica; Sigma), and the protease Type XIV
from Streptomyces griseus (Sigma).
The procedure applied in this experiment was
exactly the same as described above excepted that
the washed cells were incubated in the presence of
the different hydrolytic enzymes before the incuba-
tion with the chimeric proteins. Briefly, cell pellets
were incubated with 100 units of zymolyase 20T,
100 units of PNGase F, or 4 mg of protease in 1 mL
of 50 mM sodium phosphate buffer pH 7.4. For the
samples incubated with the zymolyase, the buffer
was supplemented with 1.2M sorbitol and 27 mM
b-mercaptoethanol. After this treatment, cells were
washed twice with 50 mM sodium phosphate buffer
and then incubated with the different chimeric
proteins. The experiment was completed exactly as
described earlier.
Antifungal activity of the chitotriosidase
and the lysozyme
The C. albicans hyphae formation inhibition assays
in solid medium were carried out according to the
procedure described by van Eijk et al.12 Briefly, a
disc, removed from an actively growing fungal cul-
ture in YPD medium (2% dextrose, 100 lg/mL of
ampicillin), was added to wells containing a fresh
YPD agar medium (2% dextrose, 100 lg/mL of ampi-
cillin, 2% agar). After 48 h of incubation at 37C,
20 lL of each tested enzyme was placed on a sterile
paper disc placed in the center of the well. The plate
was then incubated for an additional 24 h at 37C.
The enzyme concentration was 100 lM for each
tested protein. In liquid medium, filament formation
was induced by switching the culture temperature of
an actively growing fungal culture in YPD medium
(2% dextrose, 100 lg/mL of ampicillin) from 28 to
37C during 2 h. The lysozyme and chitotriosidase
concentrations used in these tests to inhibit hyphae
formation were 20, 10, 5, and 2.5 lM.
The C. albicans viability assays were performed
using a procedure modified from Samaranayake
et al.31 C. albicans yeast cells were cultured over-
night at 28C in YPD medium. Cells were harvested
and washed twice before being resuspended in a
50 mM sodium phosphate buffer; 50 mM NaCl, pH 7
to yield a final concentration of 7  106 cells/mL
(OD520 nm¼ 0.65). The cell suspension was diluted
10-fold with a 100 mM phosphate buffer, pH 7.5 con-
taining 68, 340, and 680 lM of lysozyme and chito-
triosidase. Samples were incubated for 2 h at 37C
and continually mixed. After appropriate dilutions,
the samples were plated on YPD solid media and
incubated at 37C overnight. The results are the
means of at least three independent experiments,
each carried out in duplicates or triplicates.
Biofilm formation of C. albicans in the presence
of the chitotriosidase and the lysozyme
C. albicans biofilm formation was monitored as
described by Jin et al.38 and Al-Fattani and Doug-
las.34 C. albicans was grown in YPD medium (2%
dextrose) at 28C overnight. Cells were harvested
and washed twice in 50 mM phosphate buffered sa-
line (PBS), pH 7.4. Before biofilm formation experi-
ments, all washed cell suspensions were adjusted to
an OD520 nm value of 0.38 in a yeast nitrogen base
medium. One hundred microliter of this standar-
dized cell suspension was added to the 96-well polysty-
rene plates in the presence of the tested enzyme. The
plate was incubated at 37C for 48 h to allow biofilm
formation. The growth medium was removed from each
well and nonadherent cells were removed by washing
six times with 200 lL of sterile 50 mM sodium phos-
phate buffer, pH 7.4. Finally, biofilms were stained with
110 lL of a 0.4% crystal violet aqueous solution for 45
min at room temperature. The plate was then washed
twice with sterile distilled water and destained with
200 lL of 95% ethanol. After 45 min of destaining, 100
lL of the destaining solution was transferred to a new
well and the amount of the crystal violet stain in the
destaining solution was measured at 595 nm. The final
enzyme concentrations used in this experiment were 25
lM of each isolated enzyme or in combination. Flucona-
zole was used as a negative control since Al-Fattani and
Douglas34 demonstrated that this antifungal agent is
able to inhibit C. albicans biofilm formation.
Chitinolityc activity measurements
For soluble chitooligosaccharides hydrolysis, the
enzyme preparations were incubated at 37C with
22 lM 4-methylumbelliferone-chitotriose (4-MU-chi-
totriose; Sigma) in 50 mM sodium phosphate buffer,
pH 7.5. The formed 4-MU was detected fluorometri-
cally (excitation at 366 nm and emission at 445 nm).
The final concentration of chitotriosidase was 3 nM,
for lysozyme, assays were also performed with a
10-fold higher concentration. The correlation between
the measured fluorescence intensity and the molarity
of released methylumbelliferone was realized using a
calibration curve obtained with isolated 4-MU.
For insoluble chitin hydrolysis, enzymes incu-
bated in 400 lL of 50 mM sodium phosphate buffer
pH 7.5 were mixed with 100 lL of 2 mg/mL CM-Chi-
tin-RBV. The reaction was carried out at 37C for
2 h and stopped by adding 100 lL of 2M HCl and
incubating on ice for 15 min. The absorbance of the
mixtures was measured at 520 nm after centrifuga-
tion at 12,000g for 5 min. Sodium phosphate buffer
incubated with the substrate was used as the blank.
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Crystalline chitin hydrolysis was performed
with chitin powder extracted from crab shells. One
milligram of chitin (dry weight) was incubated with
5 lM enzyme in a final volume of 1 mL of 50 mM
sodium phosphate buffer pH 7.5. After 24 h of
incubation at 25C, turbidity of the samples was
measured at 595 nm.
Lysozyme activity measurements
Detection of lysozyme activity was performed using
the EnzChekVR Lysozyme Assay Kit (E22013) (Molec-
ular Probes). This assay measures lysozyme activity
on fluorescein-labelled Micrococcus lysodeikticus cell
walls, so that the fluorescence of the label is
quenched. Lysozyme hydrolytic action relieves this
quenching. For each assay, 50 lL of the DQ lyso-
zyme substrate (50 lg/mL) is incubated in the pres-
ence of 50 lL of the kit reaction buffer and 5 lL of
the tested enzyme. Final protein concentrations in
these assays were 350 nM for each enzyme. The flu-
orescence was measured using excitation/emission
wavelengths of 494 and 518 nm, respectively. For
chitotriosidase, the assays were also performed with
a fourfold higher concentration.
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